Advanced Medicine

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.

We sit down to interview Louise Modis, Chief Scientific Officer at Mogrify, UK, about her career and role at the company.

How SaudiVax is partnering to help patients in the Middle East and Africa to access advanced medicine.

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

Gene therapy can help millions of patients with rare diseases, but one hurdle is preventing the field from achieving liftoff.

Building and managing an advanced therapy collection network is a significant challenge, but there is another route.

Allergies pose a significant challenge to patients worldwide. How can we use novel immunotherapy approaches to lessen their therapeutic burden?

SynaptixBio’s CEO discusses the personal road that led him to the fight against the rare disease H-ABC.

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.